Investigating the link between type 2 diabetes and dementia 19 July 2018 Every day scientists are learning more about the links between type 2 diabetes and dementia. Both conditions can have a major impact on a person’s quality of life as they age. This why Diabetes Australia is supporting research into how a process known as oxidative stress contributes to the development of both conditions. Dr Camilla Hoyos from the University of Sydney is leading a project which is using MRI scanning to assess levels of oxidative stress within the brain. “MRIs brain scans allow us to observe how oxidative stress is impacting on the brain,” Dr Hoyos said. “We will measure the level of oxidative stress within the brain in people with type 2 diabetes or people with prediabetes and see how this relates to changes in brain function in older adults who are ‘at risk’ of dementia. “If we can understand how dementia occurs then perhaps we can develop new methods to intervene earlier and prevent dementia.” Find out how you can support research like Dr Hoyos’ here.
Media releases 17 August 2026 Diabetes Australia to deliver Insulin Pump Program supporting children and young people Diabetes Australia has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between Diabetes Australia and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading